XML 84 R68.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders' Equity - Narrative (Details) - USD ($)
1 Months Ended 12 Months Ended 26 Months Ended
Feb. 28, 2025
Nov. 30, 2023
Dec. 26, 2025
Dec. 27, 2024
Dec. 29, 2023
Dec. 30, 2022
Dec. 26, 2025
May 17, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Warrants issued for acquisitions           $ 1,701,000    
Number of shares callable by warrants (in shares)           150,000    
Exercise price of right (in dollars per share)           $ 31.55    
Warrants outstanding (in shares)     0       0  
Number of shares available for grant (in shares)     1,543,550       1,543,550 4,230,000
Weighted average remaining term (in years)     10 years          
Stock compensation expense     $ 21,242,000 $ 17,778,000 $ 20,042,000      
Tax expense (benefit) for stock compensation     (3,570,000) (211,000) 580,000      
Options exercised during the period, intrinsic value     0 194,000 22,000      
Stock or unit option plan expense     $ 2,634,000 2,175,000 $ 2,175,000      
Stock repurchase program, program term   2 years            
Share repurchase program, authorized, amount   $ 100,000,000            
Stock repurchased during period (in shares)             667,433  
Stock repurchased during period             $ 32,400,000  
Employee Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of shares authorized (in shares)         793,000      
Fixed contribution rate         10.00%      
ESPP purchase price of common stock, percent of market price         85.00%      
Number of shares available for grant (in shares)     731,000       731,000  
Restricted share awards and restricted share units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average remaining term (in years)     1 year 8 months 12 days          
Fair value of RSAs vested     $ 17,173,000 18,370,000 $ 7,170,000      
Granted (in shares)     995,363          
Granted (in dollars per share)     $ 63.04          
Total unrecognized compensation cost     $ 25,769,000       $ 25,769,000  
Time and Performance Based Grants | Maximum                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period (in years)     5 years          
Performance-Based Restricted Awards                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average remaining term (in years)     1 year 8 months 12 days          
Granted (in shares) 541,375   740,294          
Granted (in dollars per share)     $ 63.03          
Vesting period (in years)     3 years          
Total unrecognized compensation cost     $ 10,745,000       10,745,000  
Stock or unit option plan expense     0          
Share-based compensation, term 4 years              
Fair value of awards     $ 22,235,000       22,235,000  
Time-Based Restricted Awards                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average remaining term (in years)     1 year 7 months 6 days          
Granted (in shares)     219,968          
Granted (in dollars per share)     $ 63.35          
Total unrecognized compensation cost     $ 15,024,000       $ 15,024,000  
Stock options and warrants                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting period (in years)     4 years          
Stock or unit option plan expense     $ 0 0        
Fair value of awards     $ 7,347,000 $ 4,712,000